Immunohistochemistry results from the HPA database demonstrated that EPHX2 was similarly expressed in most cancer types compared to normal tissues, aligning with mRNA expression profiles in the TCGA dataset, such as in PAAD, STAD, and BLCA(Figure 2E–J). This evidence concerns the gene EPHX2 and bladder transitional cell carcinoma.